VELIKA LOTWALA: Open Payments
NPI 1619418571 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,833 in 80 payments from 19 companies in 2025. Trend: 2023 $2,435 · 2024 $1,922 · 2025 $1,833
Food & beverage: $1,833
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $272 |
| Novartis Pharmaceuticals Corporation | 7 | $217 |
| Amgen Inc. | 4 | $189 |
| GENZYME CORPORATION | 6 | $183 |
| Galderma Laboratories, L.P. | 13 | $172 |
| ABBVIE INC. | 9 | $149 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $128 |
| Janssen Biotech, Inc. | 4 | $78 |
| Lilly USA, LLC | 4 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
Products named: DUPIXENT, OTEZLA, COSENTYX, SKYRIZI, TREMFYA, TALTZ, RINVOQ, NEMLUVIO.
Industry payments across AZ — which companies pay providers there.
